JPH0624951A - Composition for oral cavity - Google Patents
Composition for oral cavityInfo
- Publication number
- JPH0624951A JPH0624951A JP3233911A JP23391191A JPH0624951A JP H0624951 A JPH0624951 A JP H0624951A JP 3233911 A JP3233911 A JP 3233911A JP 23391191 A JP23391191 A JP 23391191A JP H0624951 A JPH0624951 A JP H0624951A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- oral cavity
- tea leaves
- present
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、歯肉の抗炎症改善効果
に優れた口腔用組成物に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an oral composition having an excellent anti-inflammatory effect on gingiva.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】従来か
ら、う蝕、即ち虫歯は、一般に口内に存在するショ糖、
口腔内細菌、及び歯の質の3つの条件が重なることによ
り発生するといわれており、そのメカニズムは、次のよ
うに考えられている。即ち、飲食物中に含まれているシ
ョ糖が口腔中に存在するストレプトコッカスミュータン
ス等の分泌する酵素であるグルコシルトランスフェラー
ゼの作用を受けて粘着性・不溶性の多糖類であるグルカ
ンを生じ、細菌巣となる歯垢を形成すると共に、歯垢中
での細菌が糖類を分解して酸を生成し、この酸が歯のエ
ナメル表面を脱灰させてう蝕を進行させるのである。ま
た、近年の高齢化社会の急速な進歩により、いわゆる歯
周病の疾患率も増大し、その予防は急務であるのも実情
である。2. Description of the Related Art Conventionally, caries, that is, dental caries, has been commonly associated with sucrose, which is present in the mouth.
It is said to occur due to the overlapping of three conditions of oral bacteria and tooth quality, and its mechanism is considered as follows. That is, sucrose contained in food and drink produces glucan, which is a sticky / insoluble polysaccharide, under the action of glucosyltransferase, which is an enzyme secreted by Streptococcus mutans present in the oral cavity. In addition to the formation of plaque, the bacteria in the plaque decompose sugars to produce acid, which decalcifies the enamel surface of the tooth and promotes caries. In addition, due to the rapid progress of the aging society in recent years, the disease rate of so-called periodontal disease has increased, and it is an urgent need to prevent it.
【0003】歯周病は、歯の周りの組織に起こる病気の
すべてをいい、歯磨等の手入れをしっかりと行わないと
炎症が慢性的になり、歯を支持する組織が崩され、最終
的には歯を失うことになる。この歯周病は、病状の進行
度や患者の年齢に応じて現れるさまざまな病型を有す
る。まず最初は、歯の生え際の表面に歯垢や歯石が付着
して歯を取り巻く歯茎が腫れて赤くなり炎症を起こす。
この炎症が長く続くと歯と歯茎の間に隙間ができ、いわ
ゆる歯周ポケットとなり、更に進むとその底にある歯槽
骨がしだいに消失してしまう。この歯周病は、痛みが伴
わず自覚症状がないままに病状が進んでいく慢性の炎症
であるが、歯茎からの出血、歯茎の腫れ、口臭などを伴
うことが多い。Periodontal disease refers to all the diseases that occur in the tissues around the teeth, and unless proper care such as tooth brushing is performed, inflammation becomes chronic, and the tissues supporting the teeth are destroyed, eventually Will lose teeth. This periodontal disease has various types of disease that appear depending on the progress of the medical condition and the age of the patient. First of all, plaque and tartar adhere to the surface of the hairline, causing the gums surrounding the tooth to swell and become red and inflamed.
If this inflammation continues for a long time, a gap is created between the teeth and gums, forming a so-called periodontal pocket, and further progressing causes the alveolar bone at the bottom to gradually disappear. This periodontal disease is a chronic inflammation that progresses without pain and without subjective symptoms, but is often accompanied by bleeding from the gums, swelling of the gums, bad breath, and the like.
【0004】従来は、このような歯周病における歯肉の
炎症を改善するものとして、グリチルリチン、ε−アミ
ノカプロン酸、ビタミンE類、アラントイン、ヒノキチ
オール等の抗炎症剤を口腔用組成物として歯磨等に配合
しているが、これらの抗炎症作用は不十分なものであ
り、上記問題を解決するには至っていない。Conventionally, anti-inflammatory agents such as glycyrrhizin, ε-aminocaproic acid, vitamin Es, allantoin, and hinokitiol have been used as oral compositions for dentifrice etc. to improve gingival inflammation in such periodontal diseases. Although they are mixed, their anti-inflammatory effects are insufficient, and the above problems have not been solved yet.
【0005】本発明者らは、上記問題点に鑑み鋭意研究
を重ねた結果、嫌気的条件下で保存処理した茶葉粉砕物
を配合することによって優れた抗炎症作用が得られるこ
とを見出だし本発明を完成したものであって、その目的
は、歯肉の炎症を抑え、歯槽膿漏、歯肉炎の予防に優れ
た効果を奏し得る口腔用組成物を提供することにある。The present inventors have conducted intensive studies in view of the above problems, and as a result, have found that an excellent anti-inflammatory effect can be obtained by incorporating a ground tea leaf product preserved under anaerobic conditions. The invention has been completed, and an object thereof is to provide an oral composition capable of suppressing inflammation of the gingiva and having an excellent effect in preventing alveolar pyorrhea and gingivitis.
【0006】[0006]
【課題を解決するための手段】上記の目的を達成する本
発明の口腔用組成物は、茶の生葉を嫌気的条件下で保存
処理した後、蒸気加熱処理及び/又は乾燥処理して得ら
れる茶葉を粉砕した粉末を配合することを特徴とするも
のである。The composition for oral cavity of the present invention which achieves the above object is obtained by subjecting fresh tea leaves to a preservation treatment under anaerobic conditions, followed by a steam heating treatment and / or a drying treatment. It is characterized by blending powder obtained by crushing tea leaves.
【0007】以下、本発明の構成の詳細について説明す
る。本発明における茶葉粉砕物は、例えば摘採した茶の
生葉を収容した容器中の空気を二酸化炭素ガス、窒素ガ
ス等の不活性ガスと充分に置換せしめた後、容器を密閉
して室温で3時間以上放置(茶葉を嫌気的条件下で保存
処理)し、その茶葉を10〜30分間蒸気加熱した後、
自然乾燥するか或いは80℃以上乾燥器内に5時間以上
入れて乾燥し、更に粉砕機にて粉末にして得ることがで
きる。The details of the configuration of the present invention will be described below. The ground tea leaves according to the present invention are, for example, 3 hours at room temperature after air is sufficiently replaced with an inert gas such as carbon dioxide gas or nitrogen gas in a container containing freshly picked tea leaves and the container is hermetically closed. After being left as it is (tea leaves are preserved under anaerobic conditions), the tea leaves are steam-heated for 10 to 30 minutes,
It can be naturally dried or put in a dryer at 80 ° C. or higher for 5 hours or more to dry, and then powdered by a pulverizer.
【0008】このようにして得られた粉末物には、γ−
アミノ酪酸の含有量が多く、これを配合した本発明の口
腔用組成物は、歯茎の血行促進作用と併せて、当該抽出
物に含まれている末梢血管拡張作用を有するテオフィリ
ン、末梢神経刺激作用を有するカフェイン、末梢血管強
化及び抗炎症作用を有するフラボノイドが相乗的に作用
し合って口腔内の歯周組織を賦活し、速効的な血行促
進、抗炎症作用を顕著に発現せしめ、更にアスパラギン
酸、グルタミン酸、アラニン、セリン、グルタミン、ア
ルギニン等のアミノ酸の保湿作用が口腔内に対して緩和
な作用を奏する。The powder obtained in this way has a γ-
The content of aminobutyric acid is high, and the oral composition of the present invention in which the aminobutyric acid is mixed, together with the blood circulation promoting action of the gum, theophylline having a peripheral vasodilatory action contained in the extract, and a peripheral nerve stimulating action Caffeine, which has the effect of strengthening peripheral blood vessels, and flavonoids, which have anti-inflammatory effects, act synergistically to activate the periodontal tissue in the oral cavity, rapidly promote blood circulation, and significantly develop anti-inflammatory effects, and asparagine. The moisturizing action of amino acids such as acids, glutamic acid, alanine, serine, glutamine, and arginine exerts a mild action on the oral cavity.
【0009】嫌気的条件下での茶葉の保存時間は、室温
(25℃)では通常3時間以上、好ましくは5時間以
上、より好ましくは8時間以上であるが、24時間を越
えないようにすることが好ましい。また、その茶葉を1
0〜30分蒸気加熱した後、自然乾燥するか、80℃以
上乾燥機内で5時間以上乾燥することにより品質の安定
した茶葉が得られる。この保存時間が短いとγ−アミノ
酪酸等の生成が充分でなく、蒸気加熱時間及び乾燥時間
が不充分だと安定な茶葉粉砕物が得られず、いずれにし
ても前記目的の口腔内血行促進、抗炎症作用の効果が充
分に発現し難く不敵である。The storage time of tea leaves under anaerobic conditions is usually 3 hours or longer at room temperature (25 ° C.), preferably 5 hours or longer, more preferably 8 hours or longer, but should not exceed 24 hours. It is preferable. Also, 1 tea leaves
After steam heating for 0 to 30 minutes, it is naturally dried or dried in a dryer at 80 ° C. or higher for 5 hours or longer to obtain stable tea leaves. If the storage time is short, the production of γ-aminobutyric acid or the like is not sufficient, and if the steam heating time and the drying time are insufficient, a stable ground tea leaf product cannot be obtained, and in any case the above-mentioned oral blood flow promotion of the purpose is promoted. , The anti-inflammatory effect is difficult to fully develop, and it is invincible.
【0010】本発明に用いる茶の生葉は、やぶきた種、
べにふじ種等、いずれの品種でも適用が可能であり、ま
た摘採時期は特に限定されない。The tea leaves used in the present invention are Yabukita seeds,
It can be applied to any variety such as Beni Fuji species, and the plucking time is not particularly limited.
【0011】本発明において前記の処理を行って得られ
た茶葉の粉砕物の配合量は、その固型分として当該口腔
用組成物の総量を基準として、0.005〜10重量%
であり、好ましくは0.01〜3重量%である。これが
0.005重量%未満では本発明が目的としている口腔
内の抗炎症効果が期待する程には発現せず、また10重
量%を越えてもその増加分に見合った効果は望めないの
で、経済的には望ましくない。In the present invention, the blended amount of the pulverized product of tea leaves obtained by performing the above treatment is 0.005 to 10% by weight based on the total amount of the oral composition as a solid component.
And preferably 0.01 to 3% by weight. If it is less than 0.005% by weight, the anti-inflammatory effect in the oral cavity aimed at by the present invention does not appear as expected, and if it exceeds 10% by weight, the effect commensurate with the increase cannot be expected. Not economically desirable.
【0012】本発明に係る口腔用組成物としては、練歯
磨、粉歯磨、トローチ、パスタ、塗付剤等が例示され
る。その他、チューインガム、キャンディー、グミキャ
ンデー、アメ等も挙げられる。Examples of the oral composition according to the present invention include toothpaste, powdered toothpaste, troches, pasta, and coating agents. In addition, chewing gum, candy, gummy candy, candy and the like can be mentioned.
【0013】本発明の他の配合成分は、口腔用組成物の
種類に応じて適宜選択される。例えば練歯磨の場合は、
一般に研磨剤として使用されている、炭酸カルシウム、
炭酸マグネシウム、第2リン酸カルシウム、第3リン酸
カルシウム、リン酸マグネシウム、シリカ、ゼオライ
ト、メタリン酸ナトリウム、水酸化アルミニウム、水酸
化マグネシウム、ピロリン酸カルシウム、ベンガラ、硫
酸カルシウム等が挙げられる。The other compounding ingredients of the present invention are appropriately selected according to the kind of the oral composition. For example, in the case of toothpaste,
Calcium carbonate, which is commonly used as an abrasive,
Examples thereof include magnesium carbonate, dicalcium phosphate, tricalcium phosphate, magnesium phosphate, silica, zeolite, sodium metaphosphate, aluminum hydroxide, magnesium hydroxide, calcium pyrophosphate, red iron oxide, and calcium sulfate.
【0014】また、カルボキシメチルセルロース、カル
ボキシメチルセルロースナトリウム、ヒドロキシエチル
セルロース、アルギン酸塩、カラギーナン、アラビアガ
ム、ポリビニルアルコール、メチルセルロース、酸化マ
グネシウム、アルミナゾル、ケイ酸カルシウム、ペクチ
ン、グアガム、カオリン、キサンタンガム等の粘結剤、
ラウリル硫酸ナトリウム、ドデシルベンゼンスルホン酸
ナトリウム、ラウロイルスルホ酢酸ナトリウム、N−ラ
ウリルスルホン酸ナトリウム、N−ラウロイルザルコシ
ン酸ナトリウム、ショ糖脂肪酸エステル、ポリオキシエ
チレンソルビタン、アルキロールアミド等の発泡剤が使
用される。Further, a binder such as carboxymethyl cellulose, sodium carboxymethyl cellulose, hydroxyethyl cellulose, alginate, carrageenan, gum arabic, polyvinyl alcohol, methyl cellulose, magnesium oxide, alumina sol, calcium silicate, pectin, guar gum, kaolin, xanthan gum, etc.,
Blowing agents such as sodium lauryl sulfate, sodium dodecylbenzene sulfonate, sodium lauroyl sulfoacetate, sodium N-lauryl sulfonate, sodium N-lauroyl sarcosinate, sucrose fatty acid ester, polyoxyethylene sorbitan, and alkylolamide are used. It
【0015】更に、サッカリンナトリウム、ステビオサ
イト、グリチルリチン、カルコン、ジヒドロカルコン等
の甘味料、グリセリン、ソルビトール、プロピレングリ
コール、ポリエチレングリコール、キリシトール、ジプ
ロピレングリコール、乳酸ナトリウム、マルチトール等
の保湿剤、パラオキシ安息香酸等の防腐剤、ペパーミン
ト、スペアミント精油、 l−メントール等の香料、その
他乳酸アルミニウム、エデト酸塩、色素、BHT等が使
用され、必要に応じてその他の有効成分として、塩化リ
ゾチーム、デキストラーゼ、溶菌酵素、ムタナーゼ、ソ
ルビン酸、アレキシジン、セチルピリジニウムクロライ
ド、アルキルグリシン、塩化ナトリウム、アラントイ
ン、ε−アミノカプロン酸、トラネキサム酸、アズレ
ン、フッ化ナトリウム、モノフルオロリン酸ナトリウム
等のフッ化物、イソプロピルメチルフェノール、ポリエ
チレングリコール、ポリビニルピロリドン、グリチルリ
チン、グリチルリチン酸、ヒノキチオール、ビタミンE
等も使用できる。尚、これらの成分は、水とを混合し、
常法に従い製造する。また、トローチ、チューイングガ
ム、キャンディ、グミキャンディーその他においても、
製品の性状に応じた成分が適宜配合される。Further, sweeteners such as sodium saccharin, stevisite, glycyrrhizin, chalcone, dihydrochalcone, moisturizers such as glycerin, sorbitol, propylene glycol, polyethylene glycol, chrysitol, dipropylene glycol, sodium lactate, maltitol, paraoxybenzoic scent. Preservatives such as acids, peppermint, spearmint essential oils, fragrances such as l-menthol, other aluminum lactate, edetate, pigments, BHT, etc. are used, and if necessary, other active ingredients such as lysozyme chloride, dextrase, Lytic enzyme, mutanase, sorbic acid, alexidine, cetylpyridinium chloride, alkylglycine, sodium chloride, allantoin, ε-aminocaproic acid, tranexamic acid, azulene, sodium fluoride, Fluoride such as sodium monofluorophosphate, isopropylmethylphenol, polyethylene glycol, polyvinylpyrrolidone, glycyrrhizin, glycyrrhizic acid, hinokitiol, vitamin E
Etc. can also be used. In addition, these components are mixed with water,
It is manufactured according to a conventional method. Also, in lozenges, chewing gum, candy, gummy candies, etc.,
Ingredients are appropriately mixed according to the properties of the product.
【0016】[0016]
【実施例】以下、実施例及び比較例に基づき本発明を詳
細に説明する。 (嫌気的条件で処理した茶葉抽出物の製造方法)摘採し
た茶生葉500gを2l入り真空用デシケーターに入
れ、その上に磁器製の多孔質板を乗せ、縁にグリースを
塗布した蓋で密封してから真空にし、更に窒素ボンベに
接続をして容器内に窒素を流入せしめ、容器内の圧力が
0.8気圧になったところで窒素の流入を中止し、室温
25℃にて約10時間放置した。その後、嫌気的条件下
で処理した茶葉を容器より取出し、蒸篭に入れて30分
間蒸気で蒸してから乾燥したタオルの上に広げ、2昼夜
25℃の部屋に放置して自然乾燥した。EXAMPLES The present invention will be described in detail below based on examples and comparative examples. (Method for producing tea leaf extract treated under anaerobic conditions) 500 g of freshly harvested tea leaves was placed in a vacuum desiccator containing 2 liters, a porcelain porous plate was placed on the desiccator, and the lid was sealed with a grease-coated lid. After making the vacuum, connect it to a nitrogen cylinder and allow nitrogen to flow into the container. When the pressure inside the container reached 0.8 atm, stop the flow of nitrogen and leave it at room temperature 25 ° C for about 10 hours. did. Then, the tea leaves treated under anaerobic conditions were taken out of the container, put in a steamer, steamed with steam for 30 minutes, spread on a dry towel, and left in a room at 25 ° C for 2 days and nights to be naturally dried.
【0017】このようにして得られた茶葉100gを微
粉砕機及び凍結粉砕機にて粉砕し、ふるいにかけ80メ
ッシュパス品を得た。尚、本製造方法によって得られた
茶葉粉砕物の成分含有量の結果を表1に示す。100 g of the tea leaves thus obtained were pulverized by a fine pulverizer and a freeze pulverizer and sieved to obtain an 80 mesh pass product. Table 1 shows the results of the component contents of the ground tea leaves obtained by this production method.
【0018】[0018]
【表1】 [Table 1]
【0019】実施例1 練り歯磨 表2の組成で前記製造法により得られた茶葉粉砕物を配
合した練り歯磨(実施例1)と比較例の練り歯磨(比較
例1)とを通常の方法で調整し、以下の方法の連用試験
によって歯肉の炎症性変化を観察した。Example 1 Toothpaste A toothpaste (Example 1) containing the composition of Table 2 and the ground tea leaves obtained by the above-mentioned production method and a toothpaste of Comparative Example (Comparative Example 1) were prepared by a conventional method. The inflammatory changes in the gingiva were observed by adjusting and continuously using the following method.
【0020】[0020]
【表2】 [Table 2]
【0021】(連用試験方法)上顎前歯上部及び下顎前
歯下部に歯周疾患のあるもの20名に対して4週間の連
用試験を行った。10名に対しては1日2回約1g実施
例1の練り歯磨きをハブラシに塗布して使用させ、残り
10名には比較例1の練り歯磨きを同様に使用させた。
使用に際し、20名共、同じハブラシを使用し、ブラッ
シィングの方法も説明し、なるべく同じ条件になるよう
にした。そじて、試験開始前後の歯肉の発赤、歯肉の腫
脹、歯肉の出血について観察した。その結果を、表3に
示す。(Continuous Use Test Method) A continuous use test for 4 weeks was carried out on 20 persons who had periodontal disease on the upper part of the upper jaw and the lower part of the lower jaw. About 10 g of the toothpaste of Example 1 was applied to a toothbrush twice a day for 10 people, and the toothpaste of Comparative Example 1 was similarly used for the remaining 10 people.
At the time of use, the same toothbrush was used by all 20 people, and the brushing method was also explained so that the same conditions were achieved as much as possible. Then, gingival redness, gingival swelling, and gingival bleeding were observed before and after the test. The results are shown in Table 3.
【0022】[0022]
【表3】 [Table 3]
【0023】この結果をみれば、本発明の口腔用組成物
(練り歯磨)が、比較例のものに比べ諸特性の全てにわ
たって優れていることが明らかになる。From these results, it becomes clear that the composition for oral cavity of the present invention (toothpaste) is superior in all of the various properties to the composition of Comparative Example.
【0024】実施例2 練り歯磨 表4の組成で通常の製造方法により本発明の練り歯磨を
得た。Example 2 Toothpaste A toothpaste of the present invention was obtained with the composition shown in Table 4 by a conventional production method.
【0025】[0025]
【表4】 [Table 4]
【0026】実施例2 練り歯磨 表5の組成で通常の製造方法により本発明の粉歯磨を得
た。Example 2 Toothpaste Toothpaste of the present invention was obtained with the composition shown in Table 5 by a conventional production method.
【0027】[0027]
【表5】 [Table 5]
【0028】実施例4 チューイングガム 表6の組成で通常の製造方法により本発明のチューイン
グガムを得た。Example 4 Chewing gum A chewing gum of the present invention was obtained with the composition shown in Table 6 by a conventional production method.
【0029】[0029]
【表6】 [Table 6]
【0030】実施例5 口腔用パスタ 表7の組成で通常の製造方法により本発明の口腔用パス
タを得た。Example 5 Oral pasta Oral pasta of the present invention was obtained by the usual production method using the composition shown in Table 7.
【0031】[0031]
【表7】 [Table 7]
【0032】実施例6 キャンディー 表8の組成で通常の製造方法により本発明のキャンディ
ーを得た。Example 6 Candy A candy of the present invention having the composition shown in Table 8 was obtained by a conventional production method.
【0033】[0033]
【表8】 [Table 8]
【0034】実施例7 グミキャンディー 表9の組成で通常の製造方法により本発明のグミキャン
ディーを得た。Example 7 Gummy candy With the composition shown in Table 9, a gummy candy of the present invention was obtained by an ordinary production method.
【0035】[0035]
【表9】 [Table 9]
【0036】上記実施例2〜7の口腔用組成物を各々1
0名の被験者が1ケ月間利用した結果、歯肉の発赤、歯
肉の腫脹、歯肉の出血等に対する改善効果がみられた。
また、利用中に苦み等の不快感も全く感じなかった。1 of each of the oral compositions of Examples 2 to 7 above
As a result of being used by 0 subjects for one month, an improvement effect on redness of gingiva, swelling of gingiva, bleeding of gingiva, etc. was observed.
Moreover, no discomfort such as bitterness was felt during use.
【0037】[0037]
【発明の効果】以上より、本発明が、歯肉の発赤、腫
脹、出血等を伴う炎症に対して優れた改善効果を奏し、
更には歯槽膿漏、歯肉炎等の予防にも有効な有用なる口
腔用組成物を提供することは明らかである。As described above, the present invention has an excellent effect of improving inflammation associated with gingival redness, swelling, bleeding, etc.
Furthermore, it is clear that the present invention provides a useful oral composition which is effective in preventing alveolar pyorrhea, gingivitis and the like.
Claims (1)
蒸気加熱処理及び/又は乾燥処理して得られる茶葉を粉
砕した粉末を配合することを特徴とする口腔用組成物。1. After storing fresh tea leaves under anaerobic conditions,
A composition for oral cavity, which comprises blending powder obtained by pulverizing tea leaves obtained by steam heating treatment and / or drying treatment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3233911A JPH0624951A (en) | 1991-08-20 | 1991-08-20 | Composition for oral cavity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3233911A JPH0624951A (en) | 1991-08-20 | 1991-08-20 | Composition for oral cavity |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0624951A true JPH0624951A (en) | 1994-02-01 |
Family
ID=16962523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3233911A Pending JPH0624951A (en) | 1991-08-20 | 1991-08-20 | Composition for oral cavity |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0624951A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002020253A (en) * | 2000-07-05 | 2002-01-23 | Kobayashi Pharmaceut Co Ltd | Composition for oral use |
JP2002051731A (en) * | 2000-08-11 | 2002-02-19 | Toyo Shinyaku:Kk | Constipation ameliorative food containing material derived from wheat young leaf |
JP2002058449A (en) * | 2000-08-22 | 2002-02-26 | Toyo Shinyaku:Kk | Method for producing young leaf powder |
KR20140117259A (en) * | 2013-03-26 | 2014-10-07 | 우시오덴키 가부시키가이샤 | Light irradiator |
-
1991
- 1991-08-20 JP JP3233911A patent/JPH0624951A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002020253A (en) * | 2000-07-05 | 2002-01-23 | Kobayashi Pharmaceut Co Ltd | Composition for oral use |
JP2002051731A (en) * | 2000-08-11 | 2002-02-19 | Toyo Shinyaku:Kk | Constipation ameliorative food containing material derived from wheat young leaf |
JP2002058449A (en) * | 2000-08-22 | 2002-02-26 | Toyo Shinyaku:Kk | Method for producing young leaf powder |
KR20140117259A (en) * | 2013-03-26 | 2014-10-07 | 우시오덴키 가부시키가이샤 | Light irradiator |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2927850B2 (en) | Topical preparations for the treatment of symptoms of teeth and their supporting tissues | |
RU2587054C1 (en) | Oral care composition | |
US8435499B2 (en) | Toothpowder composition containing wheat flour and bamboo salt | |
JP5548969B2 (en) | Dentifrice composition | |
RU2491928C1 (en) | Artificial saliva containing amino acid and using basic amino acid for treating dry mouth | |
WO2007061328A1 (en) | Oral cavity care curative and prophylactic composition | |
WO2005049050A1 (en) | Sialagogue and, containing the same, oral composition and food composition | |
CN106727268A (en) | Oral disnitegration tablet and preparation method thereof | |
US20180318185A1 (en) | Composition for use in oral cavity | |
US20070098650A1 (en) | Dental formulation | |
JPH06179609A (en) | Composition for oral cavity application | |
JP3651544B2 (en) | Salivary secretion promoter and composition for oral cavity | |
KR101660467B1 (en) | Oral composition containing fermentative extract of lycii fructus as active ingredient | |
JPH0624951A (en) | Composition for oral cavity | |
JP2001151690A (en) | Composition for oral cavity | |
JPH1045550A (en) | Oral hygiene-promoting composition | |
KR100941670B1 (en) | Oral hygiene composition containing vegetable abrasive | |
JP3690442B2 (en) | Salivary secretion promoter, oral composition and denture stabilizer | |
JP2619841B2 (en) | Oral composition | |
JPH06219930A (en) | Composition for oral cavity | |
JPH07309733A (en) | Composition for oral cavity | |
KR101142445B1 (en) | Tooth Paste Composition Containing Argan Oil | |
JP3009961B2 (en) | Oral composition | |
KR101963215B1 (en) | Oral cleansing composition containing rice bran, rice straw, hog millet | |
RP et al. | FORMULATION AND EVALUATION OF RICE BRAN OIL INCORPORATED TOOTHPASTE FOR ORAL HYGIENE |